CONMED | CNMD - Equity Capital And Reserves


CONMED reported $1.06B in Equity Capital and Reserves for its fiscal quarter ending in September of 2026.





Equity Capital And Reserves Change Date
3M USD 4.13B 1.18B Sep/2026
Abbott USD 51.03B 83M Sep/2026
Accuray USD 53.42M 8.45M Dec/2025
AtriCure USD 533.22M 16.79M Sep/2026
Baxter International USD 6.5B 296M Sep/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Boston Scientific USD 25.63B 700M Sep/2026
CONMED USD 1.06B 18.53M Sep/2026
Cooper Companies USD 8.33B 89.1M Jun/2026
Dexcom USD 2.54B 86M Sep/2026
Edwards Lifesciences USD 10.86B 243.1M Sep/2026
Globus Medical USD 4.8B 27.65M Sep/2026
Inogen USD 197.18M 2.32M Sep/2025
Insulet USD 1.58B 156.9M Sep/2026
Integra LifeSciences USD 1.07B 23.24M Sep/2026
Intuitive Surgical USD 15.99B 2.18B Sep/2026
J&J USD 81.53B 3.44B Sep/2026
Medtronic USD 50.23B 160M Jun/2026
Merit Medical Systems USD 1.74B 64.75M Sep/2026
Olympus JPY 755.41B 7.51B Sep/2026
Orthofix International USD 429.57M 387K Sep/2026
ResMed USD 5.95B 637.7M Sep/2026
Smith & Nephew USD 5.18B 356M Jun/2026
Steris USD 7.21B 23.1M Jun/2026
Stryker USD 23.99B 1.01B Jun/2026
Tandem Diabetes Care USD 135.09M 4.7M Sep/2026
Teleflex USD 3.49B 589.18M Sep/2026
Zimmer Biomet Holdings USD 12.72B 83.1M Sep/2026